newsfilter
← Latest News
FDA Approved Drugs·

Approval of Leqvio, Nda #214012 (Labeling)

Approval Date: 08/19/2026; Drug Name: Leqvio, Nda #214012; Active Ingredients: INCLISIRAN SODIUM; Company: Novartis; Submission Status: Approval; Submission Classification: Labeling; Application Number: 214012

Company
NOVARTIS
Keywords
NOVARTIS